During the past decade, Universitaetsklinikum Dusseldorf Klinik fuer Haematologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie" #1 collaborator was "Wyeth is now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie" are "Multiple Myeloma" (6 trials), "Myelodysplastic Syndrome" (2 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie" in a lesser frequency.

Most popular intervention types in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (3 trials), "Lenalidomide" (3 trials), "Bortezomib" (2 trials), "A (Thalidomide + Dexamethasone)" (1 trials) and "B (Placebo + Dexamethasone)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinikum Dusseldorf Klinik fuer Haematologie". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Universitaetsklinikum Dusseldorf Klinik fuer Haematologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinikum Dusseldorf Klinik fuer Haematologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".